Andrivet P, Cadranel J, Housset B, Herigault R, Harf A, Adnot S
Service d'explorations Fonctionnelles Respiratoires, Hôpital Universitaire Henri Mondor, Creteil, France.
Chest. 1993 Feb;103(2):500-7. doi: 10.1378/chest.103.2.500.
The mechanisms of impaired arterial oxygenation that occur in certain patients with chronic liver cirrhosis are still debated. In the present study, we investigated nine cirrhotic patients with severe respiratory disability (mean PaO2, 64 +/- 5 mm Hg), using the inert gas elimination technique to assess the distribution of ventilation-perfusion (VA/Q) ratios. We also determined shunt fraction during pure oxygen breathing, both in supine and sitting positions. To test the hypothesis that vasodilating prostaglandins could contribute to alter gas exchange in such patients with cirrhosis, we examined the hemodynamic and gasometric responses to indomethacin, 50 mg IV, in six of them. During baseline conditions, patients had high cardiac index (CI, 4.9 +/- 0.2 L/min/m2), and low pulmonary (PVR, 1.78 +/- 0.37 mm Hg/L/min/m2) or systemic (SVR, 17.7 +/- 1.15 mm Hg/L/min/m2) vascular resistances. Large intrapulmonary shunt fraction was documented in each patient with a mean value of 19.6 +/- 2.7 percent. Small perfusion in low VA/Q areas was associated with shunt in only three patients (2.5 to 5.3 percent of blood flow). Arterial PO2 was negatively related to shunt (p < 0.01) and to the dispersion of blood flow distribution (p < 0.02). There was no difference between measured and predicted PaO2. Shunt estimates from the inert gas and the 100 percent O2 breathing techniques were, respectively, 19.6 +/- 2.7 percent and 21.7 +/- 3.0 percent. During 100 percent oxygen breathing, changing from supine to sitting position decreased PaO2 from 401 +/- 50 to 333 +/- 64 mm Hg (p < 0.02), while O2 shunt remained unchanged, arteriovenous difference widened, and mixed venous PO2 decreased, from 61 +/- 3 to 47 +/- 4 mm Hg (p < 0.001). Indomethacin did not improve gas exchange or VA/Q distribution and did not affect systemic or pulmonary hemodynamics. The results show that in cirrhotic patients with severe respiratory disability, intrapulmonary shunting is the main determinant of impaired gas exchange, with no evidence of a defect in oxygen diffusion or an extrapulmonary shunt. Vasodilating prostaglandins do not appear to contribute to these alterations.
某些慢性肝硬化患者出现动脉氧合受损的机制仍存在争议。在本研究中,我们使用惰性气体清除技术评估通气-灌注(VA/Q)比值分布,对9例患有严重呼吸功能障碍的肝硬化患者(平均动脉血氧分压[PaO2]为64±5 mmHg)进行了研究。我们还测定了患者在纯氧呼吸时仰卧位和坐位的分流分数。为了验证血管舒张性前列腺素可能导致此类肝硬化患者气体交换改变这一假设,我们对其中6例患者静脉注射50 mg吲哚美辛,并检测其血流动力学和气体测量反应。在基线条件下,患者的心指数(CI)较高(4.9±0.2 L/min/m²),肺血管阻力(PVR,1.78±0.37 mmHg/L/min/m²)或体循环血管阻力(SVR,17.7±1.15 mmHg/L/min/m²)较低。每例患者均存在较大的肺内分流分数,平均值为19.6±2.7%。仅3例患者(占血流量的2.5%至5.3%)的低VA/Q区域存在小灌注并伴有分流。动脉血氧分压与分流(p<0.01)及血流分布离散度(p<0.02)呈负相关。实测PaO2与预测值之间无差异。通过惰性气体和100%氧气呼吸技术估算的分流分别为19.6±2.7%和21.7±3.0%。在100%氧气呼吸过程中,从仰卧位变为坐位时,PaO2从401±50 mmHg降至333±64 mmHg(p<0.02),而氧分流保持不变,动静脉差值增大,混合静脉血氧分压从61±3 mmHg降至47±4 mmHg(p<0.001)。吲哚美辛未改善气体交换或VA/Q分布,也未影响体循环或肺循环血流动力学。结果表明,在患有严重呼吸功能障碍的肝硬化患者中,肺内分流是气体交换受损的主要决定因素,没有证据表明存在氧弥散缺陷或肺外分流。血管舒张性前列腺素似乎并未导致这些改变。